Global Diagnostic Nuclear Medicines Market Growth (Status and Outlook) 2019-2024
Report ID: 124455 | Apr 2019 | No. of Pages: 164
Diagnostic radiopharmaceuticals. Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis
According to this study, over the next five years the Diagnostic Nuclear Medicines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Diagnostic Nuclear Medicines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Diagnostic Nuclear Medicines market by product type, application, key manufacturers and key regions and countries.
This study considers the Diagnostic Nuclear Medicines value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Tc-99m
F-18
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Oncology
Cardiology
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bracco Imaging
Bayer
Curium Pharmaceuticals
Nordion
Triad Isotopes
Lantheus
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Novartis
SIEMENS
Dongcheng
Navidea
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Diagnostic Nuclear Medicines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Diagnostic Nuclear Medicines market by identifying its various subsegments.
Focuses on the key global Diagnostic Nuclear Medicines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Diagnostic Nuclear Medicines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Diagnostic Nuclear Medicines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
According to this study, over the next five years the Diagnostic Nuclear Medicines market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Diagnostic Nuclear Medicines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Diagnostic Nuclear Medicines market by product type, application, key manufacturers and key regions and countries.
This study considers the Diagnostic Nuclear Medicines value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Tc-99m
F-18
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Oncology
Cardiology
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bracco Imaging
Bayer
Curium Pharmaceuticals
Nordion
Triad Isotopes
Lantheus
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Novartis
SIEMENS
Dongcheng
Navidea
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Diagnostic Nuclear Medicines consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Diagnostic Nuclear Medicines market by identifying its various subsegments.
Focuses on the key global Diagnostic Nuclear Medicines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Diagnostic Nuclear Medicines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Diagnostic Nuclear Medicines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Diagnostic Nuclear Medicines Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Diagnostic Nuclear Medicines Consumption 2014-2024
2.1.2 Diagnostic Nuclear Medicines Consumption CAGR by Region
2.2 Diagnostic Nuclear Medicines Segment by Type
2.2.1 Tc-99m
2.2.2 F-18
2.2.3 Other
2.3 Diagnostic Nuclear Medicines Consumption by Type
2.3.1 Global Diagnostic Nuclear Medicines Consumption Market Share by Type (2014-2019)
2.3.2 Global Diagnostic Nuclear Medicines Revenue and Market Share by Type (2014-2019)
2.3.3 Global Diagnostic Nuclear Medicines Sale Price by Type (2014-2019)
2.4 Diagnostic Nuclear Medicines Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Diagnostic Nuclear Medicines Consumption by Application
2.5.1 Global Diagnostic Nuclear Medicines Consumption Market Share by Application (2014-2019)
2.5.2 Global Diagnostic Nuclear Medicines Value and Market Share by Application (2014-2019)
2.5.3 Global Diagnostic Nuclear Medicines Sale Price by Application (2014-2019)
3 Global Diagnostic Nuclear Medicines by Players
3.1 Global Diagnostic Nuclear Medicines Sales Market Share by Players
3.1.1 Global Diagnostic Nuclear Medicines Sales by Players (2017-2019)
3.1.2 Global Diagnostic Nuclear Medicines Sales Market Share by Players (2017-2019)
3.2 Global Diagnostic Nuclear Medicines Revenue Market Share by Players
3.2.1 Global Diagnostic Nuclear Medicines Revenue by Players (2017-2019)
3.2.2 Global Diagnostic Nuclear Medicines Revenue Market Share by Players (2017-2019)
3.3 Global Diagnostic Nuclear Medicines Sale Price by Players
3.4 Global Diagnostic Nuclear Medicines Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Diagnostic Nuclear Medicines Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Diagnostic Nuclear Medicines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Diagnostic Nuclear Medicines by Regions
4.1 Diagnostic Nuclear Medicines by Regions
4.1.1 Global Diagnostic Nuclear Medicines Consumption by Regions
4.1.2 Global Diagnostic Nuclear Medicines Value by Regions
4.2 Americas Diagnostic Nuclear Medicines Consumption Growth
4.3 APAC Diagnostic Nuclear Medicines Consumption Growth
4.4 Europe Diagnostic Nuclear Medicines Consumption Growth
4.5 Middle East & Africa Diagnostic Nuclear Medicines Consumption Growth
5 Americas
5.1 Americas Diagnostic Nuclear Medicines Consumption by Countries
5.1.1 Americas Diagnostic Nuclear Medicines Consumption by Countries (2014-2019)
5.1.2 Americas Diagnostic Nuclear Medicines Value by Countries (2014-2019)
5.2 Americas Diagnostic Nuclear Medicines Consumption by Type
5.3 Americas Diagnostic Nuclear Medicines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Diagnostic Nuclear Medicines Consumption by Countries
6.1.1 APAC Diagnostic Nuclear Medicines Consumption by Countries (2014-2019)
6.1.2 APAC Diagnostic Nuclear Medicines Value by Countries (2014-2019)
6.2 APAC Diagnostic Nuclear Medicines Consumption by Type
6.3 APAC Diagnostic Nuclear Medicines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Diagnostic Nuclear Medicines by Countries
7.1.1 Europe Diagnostic Nuclear Medicines Consumption by Countries (2014-2019)
7.1.2 Europe Diagnostic Nuclear Medicines Value by Countries (2014-2019)
7.2 Europe Diagnostic Nuclear Medicines Consumption by Type
7.3 Europe Diagnostic Nuclear Medicines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Diagnostic Nuclear Medicines by Countries
8.1.1 Middle East & Africa Diagnostic Nuclear Medicines Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Diagnostic Nuclear Medicines Value by Countries (2014-2019)
8.2 Middle East & Africa Diagnostic Nuclear Medicines Consumption by Type
8.3 Middle East & Africa Diagnostic Nuclear Medicines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Diagnostic Nuclear Medicines Distributors
10.3 Diagnostic Nuclear Medicines Customer
11 Global Diagnostic Nuclear Medicines Market Forecast
11.1 Global Diagnostic Nuclear Medicines Consumption Forecast (2019-2024)
11.2 Global Diagnostic Nuclear Medicines Forecast by Regions
11.2.1 Global Diagnostic Nuclear Medicines Forecast by Regions (2019-2024)
11.2.2 Global Diagnostic Nuclear Medicines Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Diagnostic Nuclear Medicines Forecast by Type
11.8 Global Diagnostic Nuclear Medicines Forecast by Application
12 Key Players Analysis
12.1 Bracco Imaging
12.1.1 Company Details
12.1.2 Diagnostic Nuclear Medicines Product Offered
12.1.3 Bracco Imaging Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Bracco Imaging News
12.2 Bayer
12.2.1 Company Details
12.2.2 Diagnostic Nuclear Medicines Product Offered
12.2.3 Bayer Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Bayer News
12.3 Curium Pharmaceuticals
12.3.1 Company Details
12.3.2 Diagnostic Nuclear Medicines Product Offered
12.3.3 Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Curium Pharmaceuticals News
12.4 Nordion
12.4.1 Company Details
12.4.2 Diagnostic Nuclear Medicines Product Offered
12.4.3 Nordion Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Nordion News
12.5 Triad Isotopes
12.5.1 Company Details
12.5.2 Diagnostic Nuclear Medicines Product Offered
12.5.3 Triad Isotopes Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Triad Isotopes News
12.6 Lantheus
12.6.1 Company Details
12.6.2 Diagnostic Nuclear Medicines Product Offered
12.6.3 Lantheus Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Lantheus News
12.7 GE Healthcare
12.7.1 Company Details
12.7.2 Diagnostic Nuclear Medicines Product Offered
12.7.3 GE Healthcare Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 GE Healthcare News
12.8 China Isotope & Radiation
12.8.1 Company Details
12.8.2 Diagnostic Nuclear Medicines Product Offered
12.8.3 China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 China Isotope & Radiation News
12.9 Jubilant Pharma
12.9.1 Company Details
12.9.2 Diagnostic Nuclear Medicines Product Offered
12.9.3 Jubilant Pharma Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Jubilant Pharma News
12.10 Eli Lilly
12.10.1 Company Details
12.10.2 Diagnostic Nuclear Medicines Product Offered
12.10.3 Eli Lilly Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Eli Lilly News
12.11 Novartis
12.12 SIEMENS
12.13 Dongcheng
12.14 Navidea
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Diagnostic Nuclear Medicines
Table Product Specifications of Diagnostic Nuclear Medicines
Figure Diagnostic Nuclear Medicines Report Years Considered
Figure Market Research Methodology
Figure Global Diagnostic Nuclear Medicines Consumption Growth Rate 2014-2024 (K Units)
Figure Global Diagnostic Nuclear Medicines Value Growth Rate 2014-2024 ($ Millions)
Table Diagnostic Nuclear Medicines Consumption CAGR by Region 2014-2024 ($ Millions)
Figure Product Picture of Tc-99m
Table Major Players of Tc-99m
Figure Product Picture of F-18
Table Major Players of F-18
Figure Product Picture of Other
Table Major Players of Other
Table Global Consumption Sales by Type (2014-2019)
Table Global Diagnostic Nuclear Medicines Consumption Market Share by Type (2014-2019)
Figure Global Diagnostic Nuclear Medicines Consumption Market Share by Type (2014-2019)
Table Global Diagnostic Nuclear Medicines Revenue by Type (2014-2019) ($ million)
Table Global Diagnostic Nuclear Medicines Value Market Share by Type (2014-2019) ($ Millions)
Figure Global Diagnostic Nuclear Medicines Value Market Share by Type (2014-2019)
Table Global Diagnostic Nuclear Medicines Sale Price by Type (2014-2019)
Figure Diagnostic Nuclear Medicines Consumed in Oncology
Figure Global Diagnostic Nuclear Medicines Market: Oncology (2014-2019) (K Units)
Figure Global Diagnostic Nuclear Medicines Market: Oncology (2014-2019) ($ Millions)
Figure Global Oncology YoY Growth ($ Millions)
Figure Diagnostic Nuclear Medicines Consumed in Cardiology
Figure Global Diagnostic Nuclear Medicines Market: Cardiology (2014-2019) (K Units)
Figure Global Diagnostic Nuclear Medicines Market: Cardiology (2014-2019) ($ Millions)
Figure Global Cardiology YoY Growth ($ Millions)
Figure Diagnostic Nuclear Medicines Consumed in Other
Figure Global Diagnostic Nuclear Medicines Market: Other (2014-2019) (K Units)
Figure Global Diagnostic Nuclear Medicines Market: Other (2014-2019) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2014-2019)
Table Global Diagnostic Nuclear Medicines Consumption Market Share by Application (2014-2019)
Figure Global Diagnostic Nuclear Medicines Consumption Market Share by Application (2014-2019)
Table Global Diagnostic Nuclear Medicines Value by Application (2014-2019)
Table Global Diagnostic Nuclear Medicines Value Market Share by Application (2014-2019)
Figure Global Diagnostic Nuclear Medicines Value Market Share by Application (2014-2019)
Table Global Diagnostic Nuclear Medicines Sale Price by Application (2014-2019)
Table Global Diagnostic Nuclear Medicines Sales by Players (2017-2019) (K Units)
Table Global Diagnostic Nuclear Medicines Sales Market Share by Players (2017-2019)
Figure Global Diagnostic Nuclear Medicines Sales Market Share by Players in 2017
Figure Global Diagnostic Nuclear Medicines Sales Market Share by Players in 2018
Table Global Diagnostic Nuclear Medicines Revenue by Players (2017-2019) ($ Millions)
Table Global Diagnostic Nuclear Medicines Revenue Market Share by Players (2017-2019)
Figure Global Diagnostic Nuclear Medicines Revenue Market Share by Players in 2017
Figure Global Diagnostic Nuclear Medicines Revenue Market Share by Players in 2018
Table Global Diagnostic Nuclear Medicines Sale Price by Players (2017-2019)
Figure Global Diagnostic Nuclear Medicines Sale Price by Players in 2018
Table Global Diagnostic Nuclear Medicines Manufacturing Base Distribution and Sales Area by Players
Table Players Diagnostic Nuclear Medicines Products Offered
Table Diagnostic Nuclear Medicines Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table Global Diagnostic Nuclear Medicines Consumption by Regions 2014-2019 (K Units)
Table Global Diagnostic Nuclear Medicines Consumption Market Share by Regions 2014-2019
Figure Global Diagnostic Nuclear Medicines Consumption Market Share by Regions 2014-2019
Table Global Diagnostic Nuclear Medicines Value by Regions 2014-2019 ($ Millions)
Table Global Diagnostic Nuclear Medicines Value Market Share by Regions 2014-2019
Figure Global Diagnostic Nuclear Medicines Value Market Share by Regions 2014-2019
Figure Americas Diagnostic Nuclear Medicines Consumption 2014-2019 (K Units)
Figure Americas Diagnostic Nuclear Medicines Value 2014-2019 ($ Millions)
Figure APAC Diagnostic Nuclear Medicines Consumption 2014-2019 (K Units)
Figure APAC Diagnostic Nuclear Medicines Value 2014-2019 ($ Millions)
Figure Europe Diagnostic Nuclear Medicines Consumption 2014-2019 (K Units)
Figure Europe Diagnostic Nuclear Medicines Value 2014-2019 ($ Millions)
Figure Middle East & Africa Diagnostic Nuclear Medicines Consumption 2014-2019 (K Units)
Figure Middle East & Africa Diagnostic Nuclear Medicines Value 2014-2019 ($ Millions)
Table Americas Diagnostic Nuclear Medicines Consumption by Countries (2014-2019) (K Units)
Table Americas Diagnostic Nuclear Medicines Consumption Market Share by Countries (2014-2019)
Figure Americas Diagnostic Nuclear Medicines Consumption Market Share by Countries in 2018
Table Americas Diagnostic Nuclear Medicines Value by Countries (2014-2019) ($ Millions)
Table Americas Diagnostic Nuclear Medicines Value Market Share by Countries (2014-2019)
Figure Americas Diagnostic Nuclear Medicines Value Market Share by Countries in 2018
Table Americas Diagnostic Nuclear Medicines Consumption by Type (2014-2019) (K Units)
Table Americas Diagnostic Nuclear Medicines Consumption Market Share by Type (2014-2019)
Figure Americas Diagnostic Nuclear Medicines Consumption Market Share by Type in 2018
Table Americas Diagnostic Nuclear Medicines Consumption by Application (2014-2019) (K Units)
Table Americas Diagnostic Nuclear Medicines Consumption Market Share by Application (2014-2019)
Figure Americas Diagnostic Nuclear Medicines Consumption Market Share by Application in 2018
Figure United States Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure United States Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Canada Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Canada Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Mexico Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Mexico Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Table APAC Diagnostic Nuclear Medicines Consumption by Countries (2014-2019) (K Units)
Table APAC Diagnostic Nuclear Medicines Consumption Market Share by Countries (2014-2019)
Figure APAC Diagnostic Nuclear Medicines Consumption Market Share by Countries in 2018
Table APAC Diagnostic Nuclear Medicines Value by Countries (2014-2019) ($ Millions)
Table APAC Diagnostic Nuclear Medicines Value Market Share by Countries (2014-2019)
Figure APAC Diagnostic Nuclear Medicines Value Market Share by Countries in 2018
Table APAC Diagnostic Nuclear Medicines Consumption by Type (2014-2019) (K Units)
Table APAC Diagnostic Nuclear Medicines Consumption Market Share by Type (2014-2019)
Figure APAC Diagnostic Nuclear Medicines Consumption Market Share by Type in 2018
Table APAC Diagnostic Nuclear Medicines Consumption by Application (2014-2019) (K Units)
Table APAC Diagnostic Nuclear Medicines Consumption Market Share by Application (2014-2019)
Figure APAC Diagnostic Nuclear Medicines Consumption Market Share by Application in 2018
Figure China Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure China Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Japan Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Japan Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Korea Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Korea Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Southeast Asia Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Southeast Asia Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure India Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure India Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Australia Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Australia Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Table Europe Diagnostic Nuclear Medicines Consumption by Countries (2014-2019) (K Units)
Table Europe Diagnostic Nuclear Medicines Consumption Market Share by Countries (2014-2019)
Figure Europe Diagnostic Nuclear Medicines Consumption Market Share by Countries in 2018
Table Europe Diagnostic Nuclear Medicines Value by Countries (2014-2019) ($ Millions)
Table Europe Diagnostic Nuclear Medicines Value Market Share by Countries (2014-2019)
Figure Europe Diagnostic Nuclear Medicines Value Market Share by Countries in 2018
Table Europe Diagnostic Nuclear Medicines Consumption by Type (2014-2019) (K Units)
Table Europe Diagnostic Nuclear Medicines Consumption Market Share by Type (2014-2019)
Figure Europe Diagnostic Nuclear Medicines Consumption Market Share by Type in 2018
Table Europe Diagnostic Nuclear Medicines Consumption by Application (2014-2019) (K Units)
Table Europe Diagnostic Nuclear Medicines Consumption Market Share by Application (2014-2019)
Figure Europe Diagnostic Nuclear Medicines Consumption Market Share by Application in 2018
Figure Germany Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Germany Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure France Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure France Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure UK Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure UK Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Italy Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Italy Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Russia Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Russia Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Spain Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Spain Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Table Middle East & Africa Diagnostic Nuclear Medicines Consumption by Countries (2014-2019) (K Units)
Table Middle East & Africa Diagnostic Nuclear Medicines Consumption Market Share by Countries (2014-2019)
Figure Middle East & Africa Diagnostic Nuclear Medicines Consumption Market Share by Countries in 2018
Table Middle East & Africa Diagnostic Nuclear Medicines Value by Countries (2014-2019) ($ Millions)
Table Middle East & Africa Diagnostic Nuclear Medicines Value Market Share by Countries (2014-2019)
Figure Middle East & Africa Diagnostic Nuclear Medicines Value Market Share by Countries in 2018
Table Middle East & Africa Diagnostic Nuclear Medicines Consumption by Type (2014-2019) (K Units)
Table Middle East & Africa Diagnostic Nuclear Medicines Consumption Market Share by Type (2014-2019)
Figure Middle East & Africa Diagnostic Nuclear Medicines Consumption Market Share by Type in 2018
Table Middle East & Africa Diagnostic Nuclear Medicines Consumption by Application (2014-2019) (K Units)
Table Middle East & Africa Diagnostic Nuclear Medicines Consumption Market Share by Application (2014-2019)
Figure Middle East & Africa Diagnostic Nuclear Medicines Consumption Market Share by Application in 2018
Figure Egypt Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Egypt Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure South Africa Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure South Africa Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Israel Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Israel Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Turkey Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Turkey Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure GCC Countries Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure GCC Countries Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Table Diagnostic Nuclear Medicines Distributors List
Table Diagnostic Nuclear Medicines Customer List
Figure Global Diagnostic Nuclear Medicines Consumption Growth Rate Forecast (2019-2024) (K Units)
Figure Global Diagnostic Nuclear Medicines Value Growth Rate Forecast (2019-2024) ($ Millions)
Table Global Diagnostic Nuclear Medicines Consumption Forecast by Countries (2019-2024) (K Units)
Table Global Diagnostic Nuclear Medicines Consumption Market Forecast by Regions
Table Global Diagnostic Nuclear Medicines Value Forecast by Countries (2019-2024) ($ Millions)
Table Global Diagnostic Nuclear Medicines Value Market Share Forecast by Regions
Figure Americas Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Americas Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure APAC Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure APAC Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Europe Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Europe Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Middle East & Africa Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Middle East & Africa Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure United States Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure United States Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Canada Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Canada Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Mexico Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Mexico Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Brazil Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Brazil Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure China Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure China Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Japan Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Japan Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Korea Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Korea Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Southeast Asia Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Southeast Asia Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure India Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure India Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Australia Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Australia Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Germany Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Germany Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure France Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure France Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure UK Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure UK Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Italy Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Italy Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Russia Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Russia Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Spain Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Spain Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Egypt Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Egypt Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure South Africa Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure South Africa Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Israel Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Israel Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Turkey Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Turkey Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure GCC Countries Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure GCC Countries Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Table Global Diagnostic Nuclear Medicines Consumption Forecast by Type (2019-2024) (K Units)
Table Global Diagnostic Nuclear Medicines Consumption Market Share Forecast by Type (2019-2024)
Table Global Diagnostic Nuclear Medicines Value Forecast by Type (2019-2024) ($ Millions)
Table Global Diagnostic Nuclear Medicines Value Market Share Forecast by Type (2019-2024)
Table Global Diagnostic Nuclear Medicines Consumption Forecast by Application (2019-2024) (K Units)
Table Global Diagnostic Nuclear Medicines Consumption Market Share Forecast by Application (2019-2024)
Table Global Diagnostic Nuclear Medicines Value Forecast by Application (2019-2024) ($ Millions)
Table Global Diagnostic Nuclear Medicines Value Market Share Forecast by Application (2019-2024)
Table Bracco Imaging Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bracco Imaging Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Bracco Imaging Diagnostic Nuclear Medicines Market Share (2017-2019)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Bayer Diagnostic Nuclear Medicines Market Share (2017-2019)
Table Curium Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Curium Pharmaceuticals Diagnostic Nuclear Medicines Market Share (2017-2019)
Table Nordion Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Nordion Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Nordion Diagnostic Nuclear Medicines Market Share (2017-2019)
Table Triad Isotopes Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Triad Isotopes Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Triad Isotopes Diagnostic Nuclear Medicines Market Share (2017-2019)
Table Lantheus Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lantheus Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Lantheus Diagnostic Nuclear Medicines Market Share (2017-2019)
Table GE Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GE Healthcare Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure GE Healthcare Diagnostic Nuclear Medicines Market Share (2017-2019)
Table China Isotope & Radiation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure China Isotope & Radiation Diagnostic Nuclear Medicines Market Share (2017-2019)
Table Jubilant Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Jubilant Pharma Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Jubilant Pharma Diagnostic Nuclear Medicines Market Share (2017-2019)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Eli Lilly Diagnostic Nuclear Medicines Market Share (2017-2019)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table SIEMENS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dongcheng Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Navidea Basic Information, Manufacturing Base, Sales Area and Its Competitors
2019-2024 Global Diagnostic Nuclear Medicines Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Diagnostic Nuclear Medicines Consumption 2014-2024
2.1.2 Diagnostic Nuclear Medicines Consumption CAGR by Region
2.2 Diagnostic Nuclear Medicines Segment by Type
2.2.1 Tc-99m
2.2.2 F-18
2.2.3 Other
2.3 Diagnostic Nuclear Medicines Consumption by Type
2.3.1 Global Diagnostic Nuclear Medicines Consumption Market Share by Type (2014-2019)
2.3.2 Global Diagnostic Nuclear Medicines Revenue and Market Share by Type (2014-2019)
2.3.3 Global Diagnostic Nuclear Medicines Sale Price by Type (2014-2019)
2.4 Diagnostic Nuclear Medicines Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Diagnostic Nuclear Medicines Consumption by Application
2.5.1 Global Diagnostic Nuclear Medicines Consumption Market Share by Application (2014-2019)
2.5.2 Global Diagnostic Nuclear Medicines Value and Market Share by Application (2014-2019)
2.5.3 Global Diagnostic Nuclear Medicines Sale Price by Application (2014-2019)
3 Global Diagnostic Nuclear Medicines by Players
3.1 Global Diagnostic Nuclear Medicines Sales Market Share by Players
3.1.1 Global Diagnostic Nuclear Medicines Sales by Players (2017-2019)
3.1.2 Global Diagnostic Nuclear Medicines Sales Market Share by Players (2017-2019)
3.2 Global Diagnostic Nuclear Medicines Revenue Market Share by Players
3.2.1 Global Diagnostic Nuclear Medicines Revenue by Players (2017-2019)
3.2.2 Global Diagnostic Nuclear Medicines Revenue Market Share by Players (2017-2019)
3.3 Global Diagnostic Nuclear Medicines Sale Price by Players
3.4 Global Diagnostic Nuclear Medicines Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Diagnostic Nuclear Medicines Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Diagnostic Nuclear Medicines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Diagnostic Nuclear Medicines by Regions
4.1 Diagnostic Nuclear Medicines by Regions
4.1.1 Global Diagnostic Nuclear Medicines Consumption by Regions
4.1.2 Global Diagnostic Nuclear Medicines Value by Regions
4.2 Americas Diagnostic Nuclear Medicines Consumption Growth
4.3 APAC Diagnostic Nuclear Medicines Consumption Growth
4.4 Europe Diagnostic Nuclear Medicines Consumption Growth
4.5 Middle East & Africa Diagnostic Nuclear Medicines Consumption Growth
5 Americas
5.1 Americas Diagnostic Nuclear Medicines Consumption by Countries
5.1.1 Americas Diagnostic Nuclear Medicines Consumption by Countries (2014-2019)
5.1.2 Americas Diagnostic Nuclear Medicines Value by Countries (2014-2019)
5.2 Americas Diagnostic Nuclear Medicines Consumption by Type
5.3 Americas Diagnostic Nuclear Medicines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Diagnostic Nuclear Medicines Consumption by Countries
6.1.1 APAC Diagnostic Nuclear Medicines Consumption by Countries (2014-2019)
6.1.2 APAC Diagnostic Nuclear Medicines Value by Countries (2014-2019)
6.2 APAC Diagnostic Nuclear Medicines Consumption by Type
6.3 APAC Diagnostic Nuclear Medicines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Diagnostic Nuclear Medicines by Countries
7.1.1 Europe Diagnostic Nuclear Medicines Consumption by Countries (2014-2019)
7.1.2 Europe Diagnostic Nuclear Medicines Value by Countries (2014-2019)
7.2 Europe Diagnostic Nuclear Medicines Consumption by Type
7.3 Europe Diagnostic Nuclear Medicines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Diagnostic Nuclear Medicines by Countries
8.1.1 Middle East & Africa Diagnostic Nuclear Medicines Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Diagnostic Nuclear Medicines Value by Countries (2014-2019)
8.2 Middle East & Africa Diagnostic Nuclear Medicines Consumption by Type
8.3 Middle East & Africa Diagnostic Nuclear Medicines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Diagnostic Nuclear Medicines Distributors
10.3 Diagnostic Nuclear Medicines Customer
11 Global Diagnostic Nuclear Medicines Market Forecast
11.1 Global Diagnostic Nuclear Medicines Consumption Forecast (2019-2024)
11.2 Global Diagnostic Nuclear Medicines Forecast by Regions
11.2.1 Global Diagnostic Nuclear Medicines Forecast by Regions (2019-2024)
11.2.2 Global Diagnostic Nuclear Medicines Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Diagnostic Nuclear Medicines Forecast by Type
11.8 Global Diagnostic Nuclear Medicines Forecast by Application
12 Key Players Analysis
12.1 Bracco Imaging
12.1.1 Company Details
12.1.2 Diagnostic Nuclear Medicines Product Offered
12.1.3 Bracco Imaging Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Bracco Imaging News
12.2 Bayer
12.2.1 Company Details
12.2.2 Diagnostic Nuclear Medicines Product Offered
12.2.3 Bayer Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Bayer News
12.3 Curium Pharmaceuticals
12.3.1 Company Details
12.3.2 Diagnostic Nuclear Medicines Product Offered
12.3.3 Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Curium Pharmaceuticals News
12.4 Nordion
12.4.1 Company Details
12.4.2 Diagnostic Nuclear Medicines Product Offered
12.4.3 Nordion Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Nordion News
12.5 Triad Isotopes
12.5.1 Company Details
12.5.2 Diagnostic Nuclear Medicines Product Offered
12.5.3 Triad Isotopes Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Triad Isotopes News
12.6 Lantheus
12.6.1 Company Details
12.6.2 Diagnostic Nuclear Medicines Product Offered
12.6.3 Lantheus Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Lantheus News
12.7 GE Healthcare
12.7.1 Company Details
12.7.2 Diagnostic Nuclear Medicines Product Offered
12.7.3 GE Healthcare Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 GE Healthcare News
12.8 China Isotope & Radiation
12.8.1 Company Details
12.8.2 Diagnostic Nuclear Medicines Product Offered
12.8.3 China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 China Isotope & Radiation News
12.9 Jubilant Pharma
12.9.1 Company Details
12.9.2 Diagnostic Nuclear Medicines Product Offered
12.9.3 Jubilant Pharma Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Jubilant Pharma News
12.10 Eli Lilly
12.10.1 Company Details
12.10.2 Diagnostic Nuclear Medicines Product Offered
12.10.3 Eli Lilly Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Eli Lilly News
12.11 Novartis
12.12 SIEMENS
12.13 Dongcheng
12.14 Navidea
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Diagnostic Nuclear Medicines
Table Product Specifications of Diagnostic Nuclear Medicines
Figure Diagnostic Nuclear Medicines Report Years Considered
Figure Market Research Methodology
Figure Global Diagnostic Nuclear Medicines Consumption Growth Rate 2014-2024 (K Units)
Figure Global Diagnostic Nuclear Medicines Value Growth Rate 2014-2024 ($ Millions)
Table Diagnostic Nuclear Medicines Consumption CAGR by Region 2014-2024 ($ Millions)
Figure Product Picture of Tc-99m
Table Major Players of Tc-99m
Figure Product Picture of F-18
Table Major Players of F-18
Figure Product Picture of Other
Table Major Players of Other
Table Global Consumption Sales by Type (2014-2019)
Table Global Diagnostic Nuclear Medicines Consumption Market Share by Type (2014-2019)
Figure Global Diagnostic Nuclear Medicines Consumption Market Share by Type (2014-2019)
Table Global Diagnostic Nuclear Medicines Revenue by Type (2014-2019) ($ million)
Table Global Diagnostic Nuclear Medicines Value Market Share by Type (2014-2019) ($ Millions)
Figure Global Diagnostic Nuclear Medicines Value Market Share by Type (2014-2019)
Table Global Diagnostic Nuclear Medicines Sale Price by Type (2014-2019)
Figure Diagnostic Nuclear Medicines Consumed in Oncology
Figure Global Diagnostic Nuclear Medicines Market: Oncology (2014-2019) (K Units)
Figure Global Diagnostic Nuclear Medicines Market: Oncology (2014-2019) ($ Millions)
Figure Global Oncology YoY Growth ($ Millions)
Figure Diagnostic Nuclear Medicines Consumed in Cardiology
Figure Global Diagnostic Nuclear Medicines Market: Cardiology (2014-2019) (K Units)
Figure Global Diagnostic Nuclear Medicines Market: Cardiology (2014-2019) ($ Millions)
Figure Global Cardiology YoY Growth ($ Millions)
Figure Diagnostic Nuclear Medicines Consumed in Other
Figure Global Diagnostic Nuclear Medicines Market: Other (2014-2019) (K Units)
Figure Global Diagnostic Nuclear Medicines Market: Other (2014-2019) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2014-2019)
Table Global Diagnostic Nuclear Medicines Consumption Market Share by Application (2014-2019)
Figure Global Diagnostic Nuclear Medicines Consumption Market Share by Application (2014-2019)
Table Global Diagnostic Nuclear Medicines Value by Application (2014-2019)
Table Global Diagnostic Nuclear Medicines Value Market Share by Application (2014-2019)
Figure Global Diagnostic Nuclear Medicines Value Market Share by Application (2014-2019)
Table Global Diagnostic Nuclear Medicines Sale Price by Application (2014-2019)
Table Global Diagnostic Nuclear Medicines Sales by Players (2017-2019) (K Units)
Table Global Diagnostic Nuclear Medicines Sales Market Share by Players (2017-2019)
Figure Global Diagnostic Nuclear Medicines Sales Market Share by Players in 2017
Figure Global Diagnostic Nuclear Medicines Sales Market Share by Players in 2018
Table Global Diagnostic Nuclear Medicines Revenue by Players (2017-2019) ($ Millions)
Table Global Diagnostic Nuclear Medicines Revenue Market Share by Players (2017-2019)
Figure Global Diagnostic Nuclear Medicines Revenue Market Share by Players in 2017
Figure Global Diagnostic Nuclear Medicines Revenue Market Share by Players in 2018
Table Global Diagnostic Nuclear Medicines Sale Price by Players (2017-2019)
Figure Global Diagnostic Nuclear Medicines Sale Price by Players in 2018
Table Global Diagnostic Nuclear Medicines Manufacturing Base Distribution and Sales Area by Players
Table Players Diagnostic Nuclear Medicines Products Offered
Table Diagnostic Nuclear Medicines Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table Global Diagnostic Nuclear Medicines Consumption by Regions 2014-2019 (K Units)
Table Global Diagnostic Nuclear Medicines Consumption Market Share by Regions 2014-2019
Figure Global Diagnostic Nuclear Medicines Consumption Market Share by Regions 2014-2019
Table Global Diagnostic Nuclear Medicines Value by Regions 2014-2019 ($ Millions)
Table Global Diagnostic Nuclear Medicines Value Market Share by Regions 2014-2019
Figure Global Diagnostic Nuclear Medicines Value Market Share by Regions 2014-2019
Figure Americas Diagnostic Nuclear Medicines Consumption 2014-2019 (K Units)
Figure Americas Diagnostic Nuclear Medicines Value 2014-2019 ($ Millions)
Figure APAC Diagnostic Nuclear Medicines Consumption 2014-2019 (K Units)
Figure APAC Diagnostic Nuclear Medicines Value 2014-2019 ($ Millions)
Figure Europe Diagnostic Nuclear Medicines Consumption 2014-2019 (K Units)
Figure Europe Diagnostic Nuclear Medicines Value 2014-2019 ($ Millions)
Figure Middle East & Africa Diagnostic Nuclear Medicines Consumption 2014-2019 (K Units)
Figure Middle East & Africa Diagnostic Nuclear Medicines Value 2014-2019 ($ Millions)
Table Americas Diagnostic Nuclear Medicines Consumption by Countries (2014-2019) (K Units)
Table Americas Diagnostic Nuclear Medicines Consumption Market Share by Countries (2014-2019)
Figure Americas Diagnostic Nuclear Medicines Consumption Market Share by Countries in 2018
Table Americas Diagnostic Nuclear Medicines Value by Countries (2014-2019) ($ Millions)
Table Americas Diagnostic Nuclear Medicines Value Market Share by Countries (2014-2019)
Figure Americas Diagnostic Nuclear Medicines Value Market Share by Countries in 2018
Table Americas Diagnostic Nuclear Medicines Consumption by Type (2014-2019) (K Units)
Table Americas Diagnostic Nuclear Medicines Consumption Market Share by Type (2014-2019)
Figure Americas Diagnostic Nuclear Medicines Consumption Market Share by Type in 2018
Table Americas Diagnostic Nuclear Medicines Consumption by Application (2014-2019) (K Units)
Table Americas Diagnostic Nuclear Medicines Consumption Market Share by Application (2014-2019)
Figure Americas Diagnostic Nuclear Medicines Consumption Market Share by Application in 2018
Figure United States Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure United States Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Canada Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Canada Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Mexico Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Mexico Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Table APAC Diagnostic Nuclear Medicines Consumption by Countries (2014-2019) (K Units)
Table APAC Diagnostic Nuclear Medicines Consumption Market Share by Countries (2014-2019)
Figure APAC Diagnostic Nuclear Medicines Consumption Market Share by Countries in 2018
Table APAC Diagnostic Nuclear Medicines Value by Countries (2014-2019) ($ Millions)
Table APAC Diagnostic Nuclear Medicines Value Market Share by Countries (2014-2019)
Figure APAC Diagnostic Nuclear Medicines Value Market Share by Countries in 2018
Table APAC Diagnostic Nuclear Medicines Consumption by Type (2014-2019) (K Units)
Table APAC Diagnostic Nuclear Medicines Consumption Market Share by Type (2014-2019)
Figure APAC Diagnostic Nuclear Medicines Consumption Market Share by Type in 2018
Table APAC Diagnostic Nuclear Medicines Consumption by Application (2014-2019) (K Units)
Table APAC Diagnostic Nuclear Medicines Consumption Market Share by Application (2014-2019)
Figure APAC Diagnostic Nuclear Medicines Consumption Market Share by Application in 2018
Figure China Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure China Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Japan Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Japan Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Korea Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Korea Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Southeast Asia Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Southeast Asia Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure India Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure India Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Australia Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Australia Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Table Europe Diagnostic Nuclear Medicines Consumption by Countries (2014-2019) (K Units)
Table Europe Diagnostic Nuclear Medicines Consumption Market Share by Countries (2014-2019)
Figure Europe Diagnostic Nuclear Medicines Consumption Market Share by Countries in 2018
Table Europe Diagnostic Nuclear Medicines Value by Countries (2014-2019) ($ Millions)
Table Europe Diagnostic Nuclear Medicines Value Market Share by Countries (2014-2019)
Figure Europe Diagnostic Nuclear Medicines Value Market Share by Countries in 2018
Table Europe Diagnostic Nuclear Medicines Consumption by Type (2014-2019) (K Units)
Table Europe Diagnostic Nuclear Medicines Consumption Market Share by Type (2014-2019)
Figure Europe Diagnostic Nuclear Medicines Consumption Market Share by Type in 2018
Table Europe Diagnostic Nuclear Medicines Consumption by Application (2014-2019) (K Units)
Table Europe Diagnostic Nuclear Medicines Consumption Market Share by Application (2014-2019)
Figure Europe Diagnostic Nuclear Medicines Consumption Market Share by Application in 2018
Figure Germany Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Germany Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure France Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure France Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure UK Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure UK Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Italy Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Italy Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Russia Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Russia Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Spain Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Spain Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Table Middle East & Africa Diagnostic Nuclear Medicines Consumption by Countries (2014-2019) (K Units)
Table Middle East & Africa Diagnostic Nuclear Medicines Consumption Market Share by Countries (2014-2019)
Figure Middle East & Africa Diagnostic Nuclear Medicines Consumption Market Share by Countries in 2018
Table Middle East & Africa Diagnostic Nuclear Medicines Value by Countries (2014-2019) ($ Millions)
Table Middle East & Africa Diagnostic Nuclear Medicines Value Market Share by Countries (2014-2019)
Figure Middle East & Africa Diagnostic Nuclear Medicines Value Market Share by Countries in 2018
Table Middle East & Africa Diagnostic Nuclear Medicines Consumption by Type (2014-2019) (K Units)
Table Middle East & Africa Diagnostic Nuclear Medicines Consumption Market Share by Type (2014-2019)
Figure Middle East & Africa Diagnostic Nuclear Medicines Consumption Market Share by Type in 2018
Table Middle East & Africa Diagnostic Nuclear Medicines Consumption by Application (2014-2019) (K Units)
Table Middle East & Africa Diagnostic Nuclear Medicines Consumption Market Share by Application (2014-2019)
Figure Middle East & Africa Diagnostic Nuclear Medicines Consumption Market Share by Application in 2018
Figure Egypt Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Egypt Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure South Africa Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure South Africa Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Israel Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Israel Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure Turkey Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure Turkey Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Figure GCC Countries Diagnostic Nuclear Medicines Consumption Growth 2014-2019 (K Units)
Figure GCC Countries Diagnostic Nuclear Medicines Value Growth 2014-2019 ($ Millions)
Table Diagnostic Nuclear Medicines Distributors List
Table Diagnostic Nuclear Medicines Customer List
Figure Global Diagnostic Nuclear Medicines Consumption Growth Rate Forecast (2019-2024) (K Units)
Figure Global Diagnostic Nuclear Medicines Value Growth Rate Forecast (2019-2024) ($ Millions)
Table Global Diagnostic Nuclear Medicines Consumption Forecast by Countries (2019-2024) (K Units)
Table Global Diagnostic Nuclear Medicines Consumption Market Forecast by Regions
Table Global Diagnostic Nuclear Medicines Value Forecast by Countries (2019-2024) ($ Millions)
Table Global Diagnostic Nuclear Medicines Value Market Share Forecast by Regions
Figure Americas Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Americas Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure APAC Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure APAC Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Europe Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Europe Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Middle East & Africa Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Middle East & Africa Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure United States Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure United States Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Canada Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Canada Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Mexico Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Mexico Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Brazil Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Brazil Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure China Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure China Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Japan Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Japan Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Korea Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Korea Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Southeast Asia Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Southeast Asia Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure India Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure India Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Australia Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Australia Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Germany Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Germany Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure France Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure France Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure UK Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure UK Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Italy Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Italy Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Russia Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Russia Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Spain Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Spain Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Egypt Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Egypt Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure South Africa Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure South Africa Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Israel Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Israel Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure Turkey Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure Turkey Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Figure GCC Countries Diagnostic Nuclear Medicines Consumption 2019-2024 (K Units)
Figure GCC Countries Diagnostic Nuclear Medicines Value 2019-2024 ($ Millions)
Table Global Diagnostic Nuclear Medicines Consumption Forecast by Type (2019-2024) (K Units)
Table Global Diagnostic Nuclear Medicines Consumption Market Share Forecast by Type (2019-2024)
Table Global Diagnostic Nuclear Medicines Value Forecast by Type (2019-2024) ($ Millions)
Table Global Diagnostic Nuclear Medicines Value Market Share Forecast by Type (2019-2024)
Table Global Diagnostic Nuclear Medicines Consumption Forecast by Application (2019-2024) (K Units)
Table Global Diagnostic Nuclear Medicines Consumption Market Share Forecast by Application (2019-2024)
Table Global Diagnostic Nuclear Medicines Value Forecast by Application (2019-2024) ($ Millions)
Table Global Diagnostic Nuclear Medicines Value Market Share Forecast by Application (2019-2024)
Table Bracco Imaging Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bracco Imaging Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Bracco Imaging Diagnostic Nuclear Medicines Market Share (2017-2019)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Bayer Diagnostic Nuclear Medicines Market Share (2017-2019)
Table Curium Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Curium Pharmaceuticals Diagnostic Nuclear Medicines Market Share (2017-2019)
Table Nordion Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Nordion Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Nordion Diagnostic Nuclear Medicines Market Share (2017-2019)
Table Triad Isotopes Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Triad Isotopes Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Triad Isotopes Diagnostic Nuclear Medicines Market Share (2017-2019)
Table Lantheus Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lantheus Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Lantheus Diagnostic Nuclear Medicines Market Share (2017-2019)
Table GE Healthcare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GE Healthcare Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure GE Healthcare Diagnostic Nuclear Medicines Market Share (2017-2019)
Table China Isotope & Radiation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure China Isotope & Radiation Diagnostic Nuclear Medicines Market Share (2017-2019)
Table Jubilant Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Jubilant Pharma Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Jubilant Pharma Diagnostic Nuclear Medicines Market Share (2017-2019)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Diagnostic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2017-2019)
Figure Eli Lilly Diagnostic Nuclear Medicines Market Share (2017-2019)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table SIEMENS Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dongcheng Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Navidea Basic Information, Manufacturing Base, Sales Area and Its Competitors
1. This report provides in depth analysis for changing competitive dynamics and keeps you ahead of competitors
2. It provides a forward looking perspective on different factors driving or restraining market growth
3. It provides a ten-year forecast assessed on the basis of how the market is expected to grow
4. It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of various market segments
Connect With Us
+1-707-633-0404
sales@search4research.com